Weill Cornell Medicine Enterprise Innovation translates the groundbreaking research of Weill Cornell Medicine faculty into breakthroughs in medical care. WCM Enterprise Innovation encompasses the entire spectrum of a healthy innovation ecosystem, combining the Office of BioPharma Alliances & Research Collaborations, Center for Technology Licensing at Weill Cornell Medicine (CTL @ WCM), BioVenture eLab, and the Daedalus Fund for Innovation.
Our team of best-in-class business development experts works collaboratively with a network of partners to commercialize biomedical technology. We provide a bridge between academic researchers and industry stakeholders, brokering engagements and alliances, engaging with and educating faculty about IP commercialization and business development—which includes patenting, licensing, and marketing—and developing entrepreneurial programming, education and mentoring.
December 8, 2022
June 17, 2022
June 3, 2022